Differences in cognitive profiles between Lewy body and Parkinson's disease dementia

被引:22
作者
Martini, Alice [1 ]
Weis, Luca [2 ]
Schifano, Roberta [2 ]
Pistonesi, Francesca [3 ]
Fiorenzato, Eleonora [2 ]
Antonini, Angelo [3 ]
Biundo, Roberta [2 ]
机构
[1] Keele Univ, Sch Psychol, Newcastle Under Lyme, England
[2] San Camillo Hosp IRCCS, Via Alberoni 70, I-30126 Venice, Italy
[3] Univ Padua, Dept Neurosci DNS, Padua, Italy
关键词
Parkinson's dementia; Dementia with Lewy bodies; Cognition; Mini-Mental State Examination (MMSE); Montreal Cognitive Assessment (MoCA); Feasibility; DIAGNOSTIC-CRITERIA; AMYLOID DEPOSITION; BODIES; IMPAIRMENT; ALZHEIMERS; PERFORMANCE; MULTICENTER; VALIDATION; MANAGEMENT; PATHOLOGY;
D O I
10.1007/s00702-019-02129-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) not only differ for the time of onset of cognitive deficits but also present variability in affected functions which are relevant in understanding underlying pathology. Cognitive performance of two global cognitive screening scales, the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), as well as of a neuropsychological test battery, was evaluated in 18 DLB and 21 PDD patients. Feasibility for each cognitive test was investigated. Both MMSE and MoCA are feasible assessments in PDD and DLB patients. MoCA was more sensitive in discriminating groups as higher number of DLB patients showed pathological performances on the Digit Span Forward subitem (p = 0.049). The Stroop test in PDD and the Trail Making Tests-A and B, and the Benton's judgment of line orientation tests in both groups were considered not feasible. Among feasible cognitive tests in at least one group, Rey-Osterrieth complex figure test copy (p = 0.013) and semantic fluency (p = 0.038) are sensitive in discriminating DLB from PDD cognitive profile. Trail Making Tests-A and B, the Benton's judgment of line orientation and the Stroop tests are not feasible for assessing patients with frank dementia. Longitudinal studies should not include those tasks to reduce the risk of missing data once disease progresses and dementia develops. DLB patients present more severe and widespread cognitive dysfunction than PDD, particularly in attentive, visuospatial, and language domains.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 33 条
  • [11] Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia
    Fujishiro, Hiroshige
    Iseki, Eizo
    Higashi, Shinji
    Kasanuki, Koji
    Murayama, Norio
    Togo, Takashi
    Katsuse, Omi
    Uchikado, Hirotake
    Aoki, Naoya
    Kosaka, Kenji
    Arai, Heii
    Sato, Kiyoshi
    [J]. NEUROSCIENCE LETTERS, 2010, 486 (01) : 19 - 23
  • [12] Diagnostic criteria for Parkinson disease
    Gelb, DJ
    Oliver, E
    Gilman, S
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (01) : 33 - 39
  • [13] Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies
    Hepp, Dagmar H.
    Vergoossen, Dana L. E.
    Huisman, Evelien
    Lemstra, Afina W.
    Bank, Netherlands Brain
    Berendse, Henk W.
    Rozemuller, Annemieke J.
    Foncke, Elisabeth M. J.
    van de Berg, Wilma D. J.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2016, 75 (10) : 936 - 945
  • [14] IBM Corp, 2015, IBM SPSS Statistics for Windows
  • [15] Irwin David J, 2018, J Alzheimers Dis Parkinsonism, V8, DOI 10.4172/2161-0460.1000444
  • [16] The PDQ-8: Development and validation of a short-form Parkinson's Disease Questionnaire
    Jenkinson, C
    Fitzpatrick, R
    Peto, V
    Greenhall, R
    Hyman, N
    [J]. PSYCHOLOGY & HEALTH, 1997, 12 (06) : 805 - 814
  • [17] Striatal β-amyloid deposition in Parkinson disease with dementia
    Kalaitzakis, Michail E.
    Graeber, Manuel B.
    Gentleman, Stephen M.
    Pearce, Ronald K. B.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (02) : 155 - 161
  • [18] Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort
    Kramberger, Milica G.
    Auestad, Bjorn
    Garcia-Ptacek, Sara
    Abdelnour, Carla
    Olmo, Josep Garre
    Walker, Zuzana
    Lemstra, Afina W.
    Londos, Elisabet
    Blanc, Frederic
    Bonanni, Laura
    McKeith, Ian
    Winblad, Bengt
    de Jong, Frank Jan
    Nobili, Flavio
    Stefanova, Elka
    Petrova, Maria
    Falup-Pecurariu, Cristian
    Rektorova, Irena
    Bostantjopoulou, Sevasti
    Biundo, Roberta
    Weintraub, Daniel
    Aarsland, Dag
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (03) : 787 - 795
  • [19] Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment
    Litvan, Irene
    Kieburtz, Karl
    Troster, Alexander I.
    Aarsland, Dag
    [J]. MOVEMENT DISORDERS, 2018, 33 (04) : 520 - 527
  • [20] Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
    Litvan, Irene
    Goldman, Jennifer G.
    Troester, Alexander I.
    Schmand, Ben A.
    Weintraub, Daniel
    Petersen, Ronald C.
    Mollenhauer, Brit
    Adler, Charles H.
    Marder, Karen
    Williams-Gray, Caroline H.
    Aarsland, Dag
    Kulisevsky, Jaime
    Rodriguez-Oroz, Maria C.
    Burn, David J.
    Barker, Roger A.
    Emre, Murat
    [J]. MOVEMENT DISORDERS, 2012, 27 (03) : 349 - 356